1409-1429 1409-1429 S1409-14292019000200213 Costa Rica 00 12 2019 00 12 2019 28 2 213 226

1 2001 16 1 1 113-21 2 2014 3 2017 4 2010 5 2014 34 2 2 1-3. 6 2014 7 2007 8 Grupo de Economía de la Salud 2006 9 2010 16 2-3 2-3 933-38. 10 National Center for Environmental Economics 2010 11 Australian Government. 2016 12 2014 . 13 1999 14 2013 2 5 5 362-69. 15 2008 7 15 15 91-113. 16 Caja Costarricense de Seguro Social CCSS de Costa Rica 2016 17. 2008 22 4 4 354-7 18 2002 19 2008 20 2008 32 1-13 21 1997 Second edition. 22 Canadian Agency for Drugs and Technologies in Health 2006 Third 23 Canadian Agency for Drugs and Technologies in Health 2017 Fourth 24 2017 20 372-8 25 2014 26 2013 8 12 12 1-8. 27 2018 25 1 1 25-31. 28 National Institute for Health and Care Excellence. 2012 29 2015 3 1 1 30 2015 31 2001 35 189-201. 32 2009 12 3 3 S36-41 33 1997 34. 2004 78 293-5 35. European Network for Health Technology Assessment 2015 36 2017 37. 2014 30 2 2 179-87 38 2004 30 1 1 37-54 39. 2010 138 2 2 93-7 40 2004 8 36 36 1-6. 41 2011 42. 2013 43 National Centre for Phamacoeconomics NCPE 2018 44 Frech National Autorithy for Health. 2012 45 1998 46 1997 20 10 10 527-74. 47 2017 40 2 2 76-8 48 2018 36 7 7 745-58 49 2014 50 2018 51 1999 . 52 2016 95 41 41 1-8. 53 2018 6 52 52 1-13 54 Mercosur 2013 55 2014 108 7 7 397-404 56 2017 110 3 3 98-103.